LFCR

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.04
Percentage change -0.49	%

Peers: ISRG ABT SYK MDT ZBH BSX BAX EW PEN TFX

| Held by: IWM VTI VXF DWAS IWO VTWO IWN IWC EES RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.48	Insider Own	11.76%	Shs Outstand	37.03M	Perf Week	2.39%
Market Cap	301.76M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	-25.51%	Shs Float	32.67M	Perf Month	18.98%
Enterprise Value	471.88M	PEG	-	EPS next Q	-0.10	Inst Own	67.05%	Short Float	7.03%	Perf Quarter	59.80%
Income	-49.40M	P/S	2.32	EPS this Y	-515.62%	Inst Trans	1.23%	Short Ratio	9.44	Perf Half Y	6.96%
Sales	130.31M	P/B	135.38	EPS next Y	47.37%	ROA	-18.46%	Short Interest	2.30M	Perf YTD	9.69%
Book/sh	0.06	P/C	55.68	EPS next 5Y	-	ROE	-83.58%	52W High	8.63 -5.56%	Perf Year	66.67%
Cash/sh	0.15	P/FCF	-	EPS past 3/5Y	- 86.82%	ROIC	-28.57%	52W Low	3.68 121.51%	Perf 3Y	-19.47%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-9.24% -25.46%	Gross Margin	33.45%	Volatility	3.25% 3.84%	Perf 5Y	5.30%
Dividend TTM	-	EV/Sales	3.62	EPS Y/Y TTM	38.42%	Oper. Margin	-9.26%	ATR (14)	0.31	Perf 10Y	-43.52%
Dividend Ex-Date	-	Quick Ratio	1.59	Sales Y/Y TTM	6.88%	Profit Margin	-37.91%	RSI (14)	67.11	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	2.71	EPS Q/Q	-209.93%	SMA20	7.62%	Beta	0.66	Target Price	10.00
Payout	0.00%	Debt/Eq	2.75	Sales Q/Q	-1.54%	SMA50	14.50%	Rel Volume	0.60	Prev Close	8.19
Employees	524	LT Debt/Eq	2.64	Earnings	Apr 03 AMC	SMA200	26.55%	Avg Volume	243.34K	Price	8.15
IPO	Feb 15, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	-213.33% 5.73%	Trades		Volume	145,871	Change	-0.49%

Date	Action	Analyst	Rating Change	Price Target Change
May-21-25	Initiated	William Blair	Outperform
Sep-05-24	Initiated	Craig Hallum	Buy	$8
Aug-28-24	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-20-23	Downgrade	Stephens	Overweight → Equal-Weight	$11 → $2

Jun-17-25 07:00AM	Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer (GlobeNewswire)
Jun-12-25 07:00AM	Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale (GlobeNewswire)
May-27-25 07:00AM	Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer (GlobeNewswire)
Apr-24-25 11:30AM	Laughing Water Capital Top 5 Investments (Q1 2025) (Seeking Alpha)
09:30AM	Laughing Water Capital Q1 2025 Letter (Seeking Alpha)
07:00AM	Loading…
Apr-22-25 07:00AM	Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference (GlobeNewswire)
Apr-16-25 04:05PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-14-25 07:00AM	Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer (GlobeNewswire) +6.01%
Apr-05-25 12:10PM	China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz (TipRanks)
Apr-04-25 07:09AM	Q3 2025 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) -22.32%
03:01AM	Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-03-25 07:43PM	Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript (Seeking Alpha) -5.42%
05:20PM	Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:17PM	Lifecore Biomedical: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
05:15PM	Loading…
Mar-31-25 05:15PM	Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-27-25 04:05PM	Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025 (GlobeNewswire)
Mar-17-25 07:00AM	Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome (GlobeNewswire)
Mar-07-25 09:55AM	Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now? (Insider Monkey)
07:20AM	Greenhaven Road Capitals Updates on Lifecore Biomedical (LFCR) (Insider Monkey)
Feb-26-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences (GlobeNewswire)
Feb-03-25 07:00AM	Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference (GlobeNewswire)
Jan-22-25 09:36AM	Here are Laughing Water Capitals Updates on Lifecore Biomedical (LFCR) (Insider Monkey)
Jan-17-25 05:24PM	Lifecore Biomedical Announces Special Stockholder Meeting (GlobeNewswire)
Jan-07-25 09:00AM	Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million (GlobeNewswire) -13.97%
Jan-06-25 04:05PM	Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -9.84%
Jan-03-25 09:44AM	Q2 2025 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) +14.41%
02:00AM	Lifecore Biomedical Inc (LFCR) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising ... (GuruFocus.com)
Jan-02-25 05:15PM	Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -10.36%
04:15PM	Lifecore Biomedical: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Jan-01-25 07:01AM	Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 2025 Result (GuruFocus.com)
Dec-29-24 05:00AM	What to Expect in the Markets This Week (Investopedia)
Dec-19-24 04:05PM	Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 (GlobeNewswire)
07:00AM	Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment (GlobeNewswire)
Dec-12-24 10:03AM	Heres Why Arquitos Capital Management Largely Exited Lifecore (LFCR) (Insider Monkey)
Nov-26-24 04:05PM	Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO (GlobeNewswire)
Nov-21-24 04:17PM	Lifecore Biomedical Hosts Virtual Investor Day (GlobeNewswire) -6.68%
Nov-15-24 08:44AM	Heres Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) (Insider Monkey)
Nov-12-24 04:05PM	Lifecore Biomedical to Present at Stephens Annual Investment Conference (GlobeNewswire) +7.34%
Nov-07-24 07:00AM	Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 (GlobeNewswire)
Nov-04-24 07:00AM	Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations (GlobeNewswire)
Oct-17-24 07:30AM	Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer (GlobeNewswire) +9.76%
Oct-07-24 09:12PM	Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc (GuruFocus.com) -5.39% -5.50%
01:00AM	Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
Oct-04-24 07:52AM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +14.35%
07:30AM	Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
07:20AM	Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock (GlobeNewswire)
Oct-03-24 04:05PM	Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 (GlobeNewswire) -5.33%
Oct-01-24 07:00AM	Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology (GlobeNewswire)
Sep-25-24 04:05PM	Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events (GlobeNewswire) -5.01%
Sep-19-24 07:00AM	Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational (GlobeNewswire) +8.08%
Sep-12-24 04:05PM	Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference (GlobeNewswire) +5.57%
07:00AM	Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Sep-10-24 07:00AM	Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources (GlobeNewswire)
Sep-06-24 04:05PM	Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-05-24 04:05PM	Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference (GlobeNewswire) +8.53%
Aug-29-24 07:00AM	Lifecore Biomedical Announces Chief Financial Officer Transition (GlobeNewswire)
Aug-27-24 11:59PM	Q4 2024 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) -25.24% -16.24%
Aug-26-24 05:23PM	Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update (GlobeNewswire) +5.67%
Aug-09-24 05:51PM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +8.38%
Jul-26-24 03:30AM	Laughing Water Capital is Waiting for an Investor Update from Lifecore Biomedical (LFCR) (Insider Monkey)
Jul-11-24 02:51AM	Cove Street Capital Sold its Holding in Lifecore Biomedical (LFCR) (Insider Monkey) +5.71%
Jul-01-24 08:00AM	Lifecore Biomedical Announces Cooperation Agreement with 22NW (GlobeNewswire) -7.99%
May-22-24 04:16PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-16-24 04:45PM	Lifecore Biomedical Completes Incremental Liquidity Initiatives (GlobeNewswire)
May-08-24 12:26PM	Hidden Gems: Unveiling the 10 Stocks on Hedge Funds' Radar (Insider Monkey)
May-03-24 03:31AM	Do You Believe in the Upside Trajectory of Avid Bioservices (CDMO)? (Insider Monkey)
02:44AM	Here's Why Laughing Water Capital Invested in Lifecore Biomedical (LFCR) (Insider Monkey)
Apr-22-24 10:59AM	What Made White Falcon Hold Lifecore Biomedical (LFCR)? (Insider Monkey) -5.98%
10:29AM	Endava plc (DAVA) Was Down 40% in Q1 (Insider Monkey)
Apr-19-24 04:30PM	Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report (GlobeNewswire) +5.94%
Apr-11-24 02:21AM	Do You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)? (Insider Monkey) +5.47%
Apr-01-24 08:00AM	Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress (GlobeNewswire) +9.04%
Mar-26-24 04:30PM	Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update (GlobeNewswire)
Mar-21-24 12:40PM	Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal (Zacks)
Mar-20-24 07:30AM	Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes (GlobeNewswire) -30.32%
07:00AM	Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023 (GlobeNewswire)
Feb-16-24 04:05PM	Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal (GlobeNewswire)
Feb-06-24 09:49AM	Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength? (Zacks)
Jan-30-24 12:20AM	Should You Hold Lifecore Biomedical (LFCR) for Long Term? (Insider Monkey)
Jan-12-24 04:43PM	Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report (GlobeNewswire)
Jan-08-24 03:05AM	Here's Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR) (Insider Monkey) +6.89%
Jan-05-24 08:00AM	Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements (GlobeNewswire) +12.50%
Dec-13-23 07:30AM	Lifecore Biomedical Provides Business Update (GlobeNewswire)
Nov-20-23 04:05PM	Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods (GlobeNewswire)
Nov-17-23 06:04PM	Lifecore Biomedical Avoids U.S. Prosecution Over Alleged Mexico Bribes (The Wall Street Journal)
Oct-24-23 07:48AM	Here's Why Lifecore Biomedical (LFCR) Declined in Q3 (Insider Monkey)
Oct-18-23 04:05PM	Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report (GlobeNewswire)
Oct-17-23 05:00AM	SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement (PR Newswire)
Oct-10-23 04:05PM	Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings (GlobeNewswire) +7.84%
08:43AM	Here's Why Cove Street Capital Sold Lifecore Biomedical (LFCR) (Insider Monkey)
Sep-28-23 10:00AM	Will Lifecore Biomedical (LFCR) Report Negative Q1 Earnings? What You Should Know (Zacks)
Sep-01-23 10:44AM	Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Aug-31-23 10:15PM	Q4 2023 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) -11.80%
08:50AM	Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:54AM	Lifecore Biomedical: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results (GlobeNewswire)
Aug-22-23 04:06PM	Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT (GlobeNewswire)
04:05PM	Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report (GlobeNewswire)

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
English Aron R.	10% Owner	May 27 '25	Sale	6.50	1,139,504	7,411,562	414,599	May 28 08:06 PM
English Aron R.	10% Owner	May 28 '25	Sale	7.12	150,419	1,071,555	264,180	May 28 08:06 PM
English Aron R.	10% Owner	May 23 '25	Sale	6.75	96,137	649,386	1,554,103	May 28 08:06 PM
English Aron R.	10% Owner	May 13 '25	Sale	7.00	12,334	86,353	1,650,240	May 16 11:28 AM
English Aron R.	10% Owner	May 12 '25	Sale	7.03	45,698	321,426	1,662,574	May 12 06:58 PM
English Aron R.	10% Owner	May 08 '25	Sale	7.00	5,098	35,693	1,708,972	May 12 06:58 PM
English Aron R.	10% Owner	May 09 '25	Sale	7.00	700	4,900	1,708,272	May 12 06:58 PM
English Aron R.	10% Owner	May 05 '25	Sale	7.08	24,543	173,831	1,730,618	May 07 09:09 PM
English Aron R.	10% Owner	May 07 '25	Sale	7.01	15,847	111,099	1,714,070	May 07 09:09 PM
English Aron R.	10% Owner	May 06 '25	Sale	7.05	701	4,940	1,729,917	May 07 09:09 PM
Josephs Paul	Chief Executive Officer	Jan 08 '25	Buy	5.74	17,000	97,580	559,717	Jan 08 04:10 PM
Morberg John D	Former officer	Nov 20 '24	Proposed Sale	7.17	10,000	71,691		Nov 20 10:14 AM
Morberg John D	Former officer	Nov 11 '24	Proposed Sale	6.64	30,990	205,803		Nov 12 02:43 PM
Morberg John D	Former officer	Oct 31 '24	Proposed Sale	5.68	40,989	232,888		Oct 31 04:18 PM
WYNNEFIELD PARTNERS SMALL CAP	10% Owner	Oct 03 '24	Buy	4.10	169,753	695,987	2,607,433	Oct 07 08:45 PM
WYNNEFIELD PARTNERS SMALL CAP	10% Owner	Oct 03 '24	Buy	4.10	122,930	504,013	2,095,783	Oct 07 08:45 PM
Morberg John D	Former officer	Oct 07 '24	Proposed Sale	5.19	12,617	65,482		Oct 07 01:03 PM
Morberg John D	Former officer	Sep 20 '24	Proposed Sale	5.49	15,000	82,350		Sep 20 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Lifecore Biomedical Inc

Upgrade your FINVIZ experience